| Literature DB >> 31107546 |
Mireia Obón-Santacana1,2,3, Leila Luján-Barroso2,4,5, Heinz Freisling6, Sabine Naudin6, Marie-Christine Boutron-Ruault7,8, Francesca Romana Mancini7,8, Vinciane Rebours9,10, Tilman Kühn11, Verena Katzke11, Heiner Boeing12, Anne Tjønneland13,14, Anja Olsen13, Kim Overvad15, Cristina Lasheras16, Miguel Rodríguez-Barranco3,17, Pilar Amiano3,18, Carmen Santiuste3,19, Eva Ardanaz3,20,21, Kay-Thee Khaw22, Nicholas J Wareham23, Julie A Schmidt24, Dagfinn Aune25,26,27, Antonia Trichopoulou28, Paschalis Thriskos28, Eleni Peppa28, Giovanna Masala29, Sara Grioni30, Rosario Tumino31, Salvatore Panico32, Bas Bueno-de-Mesquita33,34,35,36, Veronica Sciannameo37, Roel Vermeulen38, Emily Sonestedt39, Malin Sund40, Elisabete Weiderpass41,42, Guri Skeie43, Carlos A González2,4, Elio Riboli25, Eric J Duell2,4.
Abstract
Four epidemiologic studies have assessed the association between nut intake and pancreatic cancer risk with contradictory results. The present study aims to investigate the relation between nut intake (including seeds) and pancreatic ductal adenocarcinoma (PDAC) risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Cox proportional hazards models were used to estimate hazards ratio (HR) and 95% confidence intervals (95% CI) for nut intake and PDAC risk. Information on intake of nuts was obtained from the EPIC country-specific dietary questionnaires. After a mean follow-up of 14 years, 476,160 participants were eligible for the present study and included 1,283 PDAC cases. No association was observed between consumption of nuts and PDAC risk (highest intake vs nonconsumers: HR, 0.89; 95% CI, 0.72-1.10; p-trend = 0.70). Furthermore, no evidence for effect-measure modification was observed when different subgroups were analyzed. Overall, in EPIC, the highest intake of nuts was not statistically significantly associated with PDAC risk.Entities:
Keywords: EPIC; diet; intake; nuts; pancreatic cancer; prospective cohort study; seeds
Mesh:
Year: 2019 PMID: 31107546 PMCID: PMC7340534 DOI: 10.1002/ijc.32415
Source DB: PubMed Journal: Int J Cancer ISSN: 0020-7136 Impact factor: 7.396